Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell ...

Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational drug target discovery powered by AI/ML, today announced that the Company will ...

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Compugen (CGEN) been one of those stocks this year? Let's ...

A downtrend has been apparent in Compugen (CGEN) lately. While the stock has lost 10.3% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its last trading ...

Compugen (NASDAQ:CGEN) stock is rocketing higher on Tuesday after announcing an exclusive licensing agreement with Gilead Sciences (NASDAQ:GILD). According to a press release from Compugen, this ...

Shares of Compugen (CGEN) added ~16% in the premarket on Wednesday after the Israel-based biotech announced an agreement with AstraZeneca (AZN) to monetize a portion of future royalties linked to its ...

Compugen Ltd. Annual stock financials by MarketWatch. View the latest CGEN financial statements, income statements and financial ratios.

CGEN is trading in the middle of its 52-week range and above its 200-day simple moving average. Price change The price of CGEN shares has increased $0.01 since the market last closed. This is a 0.55% ...